UNSPSC 51262900: Adrenergic blocking agent phenoxypropanolamines

This classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.

UNSPSC 51262900 Adrenergic blocking agent phenoxypropanolamines is a Class code that in recent state and local activity captures procurement of naloxone and opioid-antagonist drug systems, though the nominal code name does not fully align with the work actually being solicited. Seminole County, Florida issued IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, reflecting municipal health department purchasing tied to opioid emergency response and community health initiatives. The Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013) to assess vendor capabilities for direct-to-manufacturer prescription programs that would bypass traditional pharmacy benefit managers and wholesalers, signaling state agency interest in alternative pharmaceutical supply models. Issuing bodies on this code include county health departments and state health and human services agencies, both focused on pharmaceutical procurement for public health missions rather than traditional clinical hospital supply chains.

Geographic activity centers on Florida and Texas based on recent postings. The Seminole County opportunity (response deadline July 26, 2023) represents municipal-level procurement with fixed-fee, unit-price bidding and a two-year initial term plus one-year renewal option, while the Texas RFI (response deadline April 3, 2026) is preliminary market research preceding formal solicitation and does not establish binding timelines or award amounts. Both opportunities reflect emerging state and local demand for drug-response systems and alternative pharmaceutical distribution channels rather than traditional hospital formulary management. Vendors pursuing this code should expect competitive bidding on unit costs, quarterly fulfillment requirements, direct-to-location delivery logistics, and federal compliance requirements including E-Verify, drug-free workplace certification, and federal environmental statutes when FEMA funding is involved.